Pigment Cell & Melanoma Research

Papers
(The TQCC of Pigment Cell & Melanoma Research is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information63
38
SASH1 Mutations and Hereditary Disorders of Pigmentation: Review of Literature33
31
Oral Melanoma in Older Adults: Epidemiology, Molecular Landscape, and Treatment Strategies30
Fusion Gene Detection in Driver Mutation‐Negative Melanomas Using RNA‐Based Anchored Multiplex Polymerase Chain Reaction29
Molecular heterogeneity of quiescent melanocyte stem cells revealed by single‐cell RNA‐sequencing28
Proceedings from the Melanoma Research Foundation Mucosal Melanoma Meeting (December 16, 2022, New York, USA)23
Let’s talk about sex: A biological variable in immune response against melanoma23
Cytoglobin functions as a redox regulator of melanogenesis in normal epidermal melanocytes21
Retrospective review of outcomes associated with metastatic melanoma patients treated with 1st‐line BRAF‐targeted therapy20
CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma19
Progress in melanoma treatment: Patient's perspectives16
25th International Pigment Cell Conference, Bilbao, Spain IPCC 202315
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma15
Microfluidic Characterization and Analysis of Circulating Tumor Cells From Patients With Metastatic Melanoma14
Issue Information14
The Melanocyte and Nerve Fiber Cross‐Talk, Facilitated Also by Semaphorin‐4A, Enhances UV‐B‐Induced Melanogenesis14
Issue Information14
Issue Information14
Impact of a SLC24A5 variant on the retinal pigment epithelium of a Japanese patient with oculocutaneous albinism type 613
12
Abstracts12
Issue Information12
Modeling of pigmentation disorders associated with MITF mutation in Waardenburg syndrome revealed an impaired melanogenesis pathway in iPS‐derived melanocytes12
Single‐cell profiling of MC1R‐inhibited melanocytes11
Sex Differences in Acral Lentiginous Melanoma: A Retrospective Cohort Analysis of 3617 Cases From the Surveillance, Epidemiology, and End Results Database10
Celebrating the life of James J. Nordlund, MD, a larger‐than‐life scholar, mentor, and friend9
PASPCR 2024 Annual Meeting, New York, NY9
Issue Information9
9
Prognostic value of clinical and radiomic parameters in patients with liver metastases from uveal melanoma8
Association Between Melanoma Metastasis and Metabolic Syndrome: A Cross‐Sectional Study in a Chinese Population8
Cover Image8
Mouse Tail‐Skin Dissociation and Preparation of Live Single‐Cell Suspension for Downstream Analysis of Melanocytes8
BORIS/CTCFL‐mediated chromatin accessibility alterations promote a pro‐invasive transcriptional signature in melanoma cells7
Cover Image7
Beyond the 5‐year milestone: Long‐term survivorship of melanoma patients treated off‐trial with anti‐PD‐17
MetFinder: A Tool for Automated Quantitation of Metastatic Burden in Histological Sections From Preclinical Models7
Rapid Diagnosis and Subtyping of Hermansky‐Pudlak Syndrome With Flow Cytometry Analysis7
Dominant Negative Mitf Allele Impacts Melanophore and Xanthophore Development and Reveals Collaborative Interactions With Tfec in Zebrafish Chromatophore Lineages7
Issue Information7
7
Meeting Report From the 2023 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Philadelphia, PA, November 20237
The delicate relation between melanocytes and skin immunity: A game of hide and seek7
Issue Information6
Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment6
Topical antibiotics limit depigmentation in a mouse model of vitiligo6
Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance6
Cover Image6
The metabolism of melanin synthesis—From melanocytes to melanoma6
Three‐dimensional imaging for the analysis of human epidermal melanocytes6
The Proposed Categorization of Vitiligo Lesions on the Hands6
Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo6
5,6‐Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation6
UVA Irradiation Promotes Melanoma Cell Proliferation Mediated by OPN3 Independently of ROS Production6
Prognostic and Predictive Value of ctDNA for Metastatic Uveal Melanoma: A Systematic Review and Meta‐Analysis5
ToFSIMS imaging reveals changes in tumor cell lipids during metastatic progression of melanoma5
Issue Information5
2‐Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity5
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants5
Unsuspected consequences of synonymous and missense variants in OCA2 can be detected in blood cell RNA samples of patients with albinism5
Segregation Between an Ornamental and a Disease Driver Gene Provides Insights Into Pigment Cell Regulation5
Patient Education in the Eye of the Beholder: Assessing the Effect of Skin Color Representation in Melanoma Educational Materials5
Induced pluripotent stem cells reprogramming overcomes technical limitations for highly pigmented adult melanocyte amplification and integration in 3D skin model5
Pathogenic Germline Variants in Uveal Melanoma Driver and BAP1‐Associated Genes in Finnish Patients with Uveal Melanoma5
Pigmentation and Retinal Pigment Epithelium Thickness: A Study of the Phenotypic and Genotypic Relationships Between Ocular and Extraocular Pigmented Tissues5
Genetic and phenotypic heterogeneity of multiple lentigines and precise diagnosis in four Chinese families with multiple lentigines5
The OSUMMER lines: A series of ultraviolet‐accelerated NRAS‐mutant mouse melanoma cell lines syngeneic to C57BL/65
Cutaneous Pigment Cell Distributions and Skin Structure of Xenopus4
Durable complete response in a patient with leptomeningeal melanoma after treatment with dabrafenib, trametinib, and nivolumab4
TFE3 promotes ferroptosis in melanoma4
Causes of death and patterns of metastatic disease at the end of life for patients with advanced melanoma in the immunotherapy era4
4
Checkpoint kinase 1 inhibitor + low‐dose hydroxyurea efficiently kills BRAF inhibitor‐ and immune checkpoint inhibitor‐resistant melanomas4
4
Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment4
The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis4
Advancements in melanoma cancer metastasis models4
Issue Information4
0.15083003044128